Carmen Ruiz-Ruiz

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Epigenetic therapies have emerged as promising anticancer approaches, since epigenetic modifications play a major role in tumor initiation and progression. Hydralazine, an approved vasodilator and antihypertensive drug, has been recently shown to act as a DNA methylation inhibitor. Even though hydralazine is already tested in clinical cancer trials, its(More)
  • 1